 CAMBRIDGE, Mass.--BUSINESS WIRE--Sage Therapeutics, Inc. NASDAQ: SAGE, a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, announced today that the Company will participate in a fireside chat at the Stifel 2021 Virtual Healthcare Conference on November 15 at 3:20pm ET. A live webcast of the fireside chat can be accessed on the Investor page of Sages website at investor.sagerx.com. 